Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article (34)

Advertisement

Research Article Free access | 10.1172/JCI114743

Two elliptocytogenic alpha I/74 variants of the spectrin alpha I domain. Spectrin Culoz (GGT----GTT; alpha I 40 Gly----Val) and spectrin Lyon (CTT----TTT; alpha I 43 Leu---Phe).

L Morlé, A F Roux, N Alloisio, B Pothier, J Starck, L Denoroy, F Morlé, R C Rudigoz, B G Forget, and J Delaunay

Centre National de la Recherche Scientifique (CNRS) URA 1171, Faculté de Médecine Grange-Blanche, Lyon, France.

Find articles by Morlé, L. in: JCI | PubMed | Google Scholar

Centre National de la Recherche Scientifique (CNRS) URA 1171, Faculté de Médecine Grange-Blanche, Lyon, France.

Find articles by Roux, A. in: JCI | PubMed | Google Scholar

Centre National de la Recherche Scientifique (CNRS) URA 1171, Faculté de Médecine Grange-Blanche, Lyon, France.

Find articles by Alloisio, N. in: JCI | PubMed | Google Scholar

Centre National de la Recherche Scientifique (CNRS) URA 1171, Faculté de Médecine Grange-Blanche, Lyon, France.

Find articles by Pothier, B. in: JCI | PubMed | Google Scholar

Centre National de la Recherche Scientifique (CNRS) URA 1171, Faculté de Médecine Grange-Blanche, Lyon, France.

Find articles by Starck, J. in: JCI | PubMed | Google Scholar

Centre National de la Recherche Scientifique (CNRS) URA 1171, Faculté de Médecine Grange-Blanche, Lyon, France.

Find articles by Denoroy, L. in: JCI | PubMed | Google Scholar

Centre National de la Recherche Scientifique (CNRS) URA 1171, Faculté de Médecine Grange-Blanche, Lyon, France.

Find articles by Morlé, F. in: JCI | PubMed | Google Scholar

Centre National de la Recherche Scientifique (CNRS) URA 1171, Faculté de Médecine Grange-Blanche, Lyon, France.

Find articles by Rudigoz, R. in: JCI | PubMed | Google Scholar

Centre National de la Recherche Scientifique (CNRS) URA 1171, Faculté de Médecine Grange-Blanche, Lyon, France.

Find articles by Forget, B. in: JCI | PubMed | Google Scholar

Centre National de la Recherche Scientifique (CNRS) URA 1171, Faculté de Médecine Grange-Blanche, Lyon, France.

Find articles by Delaunay, J. in: JCI | PubMed | Google Scholar

Published August 1, 1990 - More info

Published in Volume 86, Issue 2 on August 1, 1990
J Clin Invest. 1990;86(2):548–554. https://doi.org/10.1172/JCI114743.
© 1990 The American Society for Clinical Investigation
Published August 1, 1990 - Version history
View PDF
Abstract

Spectrin alpha I/74 elliptocytosis results from abnormalities involving the "head" region of spectrin dimer. Increased susceptibility to trypsin enhances cleavage of the alpha spectrin chain, yielding an increased amount of the alpha I 74-kD fragment at the expense of the alpha I 80-kD parent fragment. Recently we showed that the mutations causing the Sp alpha I/74 abnormality may lie in the alpha- or the beta-chain, and that spectrin Culoz and spectrin Lyon were two (alpha I/74) alpha-variants, respectively. We now show that the spectrin Culoz alpha I domain undergoes prominent tryptic cleavage after Lys 42, whereas cleavage prevails after Arg 39 in spectrin Lyon. Applying the polymerase chain reaction (PCR) technique to exon 2 of the spectrin alpha I domain, we have established that the mutation responsible for spectrin Culoz is alpha I 40 Gly----Val; GGT----GTT. Applying the PCR technique to the cDNA derived from reticulocyte mRNA, we have shown that the mutation responsible for spectrin Lyon is alpha I 43 Leu----Phe; CTT----TTT. Studies of normal controls and of family members using dot blot hybridization with allele-specific oligonucleotide probes confirmed these results. Variants such as spectrin Culoz and spectrin Lyon should provide insight into a region that participates in spectrin dimer self-association and whose susceptibility to proteolysis must reflect subtle conformational changes.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 548
page 548
icon of scanned page 549
page 549
icon of scanned page 550
page 550
icon of scanned page 551
page 551
icon of scanned page 552
page 552
icon of scanned page 553
page 553
icon of scanned page 554
page 554
Version history
  • Version 1 (August 1, 1990): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (34)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts